Literature DB >> 17307885

The structural basis of hyper IgM deficiency - CD40L mutations.

J Thusberg1, M Vihinen.   

Abstract

X-linked hyper-IgM syndrome (XHIGM) is a primary immunodeficiency characterised by an inability to produce immunoglobulins of the IgG, IgA and IgE isotypes. It is caused by mutations of CD40 ligand (CD40L, CD154), expressed on T-lymphocytes. The interaction of CD40L on T-cells and its receptor CD40 on B-cells is essential for lymphocyte signalling leading to immunoglobulin class switching and B-cell maturation. To understand the structural basis for XHIGM, we utilised bioinformatics methods to analyse all the known CD40L missense mutations at both the sequence and structural level. Our results demonstrate that the 35 different missense mutations have diverse effects on CD40L structure and function, affecting structural disorder and aggregation tendencies, stability maintaining contacts and electrostatic properties. Several mutations also affect residues essential in receptor binding and trimerisation. Experimental study of effects of mutations is laborious and time-consuming and at the structural level often almost impossible. By contrast, precise and useful information about effects of mutations on protein structure and function can readily be obtained by theoretical methods. In this study, all the XHIGM causing missense mutations could be explained in terms of CD40L structure and function. Thus, the molecular basis of the syndrome could be elucidated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17307885     DOI: 10.1093/protein/gzm004

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  18 in total

Review 1.  Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.

Authors:  A Heinold; B Hanebeck; V Daniel; J Heyder; T H Tran; B Döhler; J Greil; F-M Müller
Journal:  Infection       Date:  2010-10-28       Impact factor: 3.553

2.  Phenotypic heterogeneity in a family with a CD40 ligand intracellular domain mutation.

Authors:  S Kiani-Alikhan; P F K Yong; K C Gilmour; D Grosse-Kreul; E G Davies; M A A Ibrahim
Journal:  J Clin Immunol       Date:  2011-10-19       Impact factor: 8.317

3.  Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.

Authors:  M H Napimoga; E P Rocha; C A Trindade-da-Silva; A P D Demasi; E F Martinez; C G Macedo; H B Abdalla; A Bettaieb; F G Haj; J T Clemente-Napimoga; B Inceoglu; B D Hammock
Journal:  J Periodontal Res       Date:  2018-05-31       Impact factor: 4.419

4.  Small-molecule costimulatory blockade: organic dye inhibitors of the CD40-CD154 interaction.

Authors:  Emilio Margolles-Clark; Oliver Umland; Norma S Kenyon; Camillo Ricordi; Peter Buchwald
Journal:  J Mol Med (Berl)       Date:  2009-08-26       Impact factor: 4.599

5.  Clinical and molecular features of X-linked hyper IgM syndrome - An experience from North India.

Authors:  Amit Rawat; Babu Mathew; Vignesh Pandiarajan; Ankur Jindal; Madhubala Sharma; Deepti Suri; Anju Gupta; Shubham Goel; Adil Karim; Biman Saikia; Ranjana W Minz; Kohsuke Imai; Shigeaki Nonoyama; Osamu Ohara; Silvia Clara Giliani; Luigi D Notarangelo; Koon-Wing Chan; Yu-Lung Lau; Surjit Singh
Journal:  Clin Immunol       Date:  2018-07-25       Impact factor: 3.969

6.  Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.

Authors:  Asghar Aghamohammadi; Nima Parvaneh; Nima Rezaei; Kasra Moazzami; Sara Kashef; Hassan Abolhassani; Amir Imanzadeh; Javad Mohammadi; Lennart Hammarström
Journal:  J Clin Immunol       Date:  2009-07-03       Impact factor: 8.317

Review 7.  Mutation analysis in primary immunodeficiency diseases: case studies.

Authors:  Amy P Hsu; Thomas A Fleisher; Julie E Niemela
Journal:  Curr Opin Allergy Clin Immunol       Date:  2009-12

8.  Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction.

Authors:  Jinshui Chen; Yun Song; Damir Bojadzic; Alejandro Tamayo-Garcia; Ana Marie Landin; Bonnie B Blomberg; Peter Buchwald
Journal:  J Med Chem       Date:  2017-10-25       Impact factor: 7.446

9.  Mitochondrial DNA insert into CD40 ligand gene-associated X-linked hyper-IgM syndrome.

Authors:  Xuejing Li; Dan Xu; Beilei Cheng; Yunlian Zhou; Zhimin Chen; Yingshuo Wang
Journal:  Mol Genet Genomic Med       Date:  2021-03-24       Impact factor: 2.183

10.  PoPMuSiC 2.1: a web server for the estimation of protein stability changes upon mutation and sequence optimality.

Authors:  Yves Dehouck; Jean Marc Kwasigroch; Dimitri Gilis; Marianne Rooman
Journal:  BMC Bioinformatics       Date:  2011-05-13       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.